Bacil Pharma Limited (BOM:524516)
34.55
-1.81 (-4.98%)
At close: Oct 31, 2025
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 447.67 million as of November 5, 2025. Its market cap has increased by 183.50% in one year.
Market Cap
447.67M
Enterprise Value
420.74M
Revenue
n/a
Ranking
n/a
PE Ratio
22.33
Stock Price
34.55
Market Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 447.67M, an increase of 1,953.43%. That is a compound annual growth rate of 17.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 447.67M | 39.87% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | 27.80M | 137.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 19.93T |
| HDFC Bank | 15.14T |
| Bharti Airtel | 12.67T |
| Tata Consultancy Services | 10.82T |
| ICICI Bank | 9.55T |
| State Bank of India | 8.84T |
| Bajaj Finance | 6.56T |
| Infosys | 6.08T |